Lokesh Kumar Mende

Dr. Lokesh Kumar Mende

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JRJagadeesh Rajaram
Jagadeesh Rajaram
LMLokesh Kumar Mende
Lokesh Kumar Mende
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
Natural photosensitizers (PS) are compounds derived from nature, with photodynamic properties. Natural PSs have a similar action to that of commercial PSs, where cancer cell death occurs by necrosis, apoptosis, and autophagy through ROS generation. Natural PSs have garnered great interest over the last few decades because of their high biocompatibility and good photoactivity. Specific wavelengths could cause phytochemicals to produce harmful ROS for photodynamic therapy (PDT). However, natural PSs have some shortcomings, such as reduced solubility and lower uptake, making them less appropriate for PDT. Nanotechnology offers an opportunity to develop suitable carriers for various natural PSs for PDT applications. Various nanoparticles have been developed to improve the outcome with enhanced solubility, optical adsorption, and tumor targeting. Multidrug resistance (MDR) is a phenomenon in which tumor cells develop resistance to a wide range of structurally and functionally unrelated drugs. Over the last decade, several researchers have extensively studied the effect of natural PS-based photodynamic treatment (PDT) on MDR cells. Though the outcomes of clinical trials for natural PSs were inconclusive, significant advancement is still required before PSs can be used as a PDT agent for treating MDR tumors. This review addresses the increasing literature on MDR tumor progression and the efficacy of PDT, emphasizing the importance of developing new nano-based natural PSs in the fight against MDR that have the required features for an MDR tumor photosensitizing regimen.

19 January 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
LMLokesh Kumar Mende
Lokesh Kumar Mende
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
CWChih-Shung Wong
Chih-Shung Wong
Background: Knee osteoarthritis (OA) is a common and debilitating disorder marked by joint degradation, inflammation, and persistent pain. This study examined the possible therapeutic effects of curcumin and vitamin D on OA progression and pain in a rat knee OA model by anterior cruciate ligament transection and meniscectomy (ACLT + MMx). Methods: Male Wistar rats were categorized into five groups: control, curcumin-treated (100 mg/kg/day), vitamin D-treated (25 µg/kg/day), a combination of vitamin D and curcumin, and sham-operated. All supplements were administered orally on a daily basis for 12 weeks. Pain behaviors were assessed, serum biomarkers were measured, and knee histology was examined. Results: Both curcumin and vitamin D independently reduced pain, while the combined group exhibited better analgesic effects. Serum inflammatory cytokines demonstrated a decrease in pro-inflammatory cytokines and an elevation in anti-inflammatory cytokine interleukin-10 (IL-10) in the supplement groups. The antioxidative markers were partially recovered by curcumin and vitamin D supplement. However, the oxidative stress marker Cartilage Oligomeric Matrix Protein (COMP) was significantly reduced. Histology analysis revealed a preservation of joint architecture and cartilage integrity and decreased synovium inflammation in the groups treated with curcumin and vitamin D. Conclusions: Our findings indicate a dual mechanism that encompasses the role of anti-inflammation and antioxidation on knee OA progression and pain reduction, underscoring the potential of these natural chemicals as therapeutic agents for knee OA; curcumin and vitamin D supplement may be added in delaying knee OA progression and associated pain management in clinical patient care.

27 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
TYTsu-Te Yeh
Tsu-Te Yeh
CCChun-Kai Chen
Chun-Kai Chen
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
LMLokesh Kumar Mende
Lokesh Kumar Mende
CWChih-Shung Wong
Chih-Shung Wong
ZKZwe-Ling Kong
Zwe-Ling Kong
Background: Delayed and failed fracture repair and bone healing remain significant public health issues. Dietary supplements serve as a safe, inexpensive, and non-surgical means to aid in different stages of fracture repair. Studies have shown that amorphous calcium carbonate (ACC) is absorbed 2 to 4.6 times more than crystalline calcium carbonate in humans. Objectives: In the present study, we assessed the efficacy of ACC on femoral fracture healing in a male Wistar rat model. Methods: Eighty male Wistar rats were randomly divided into five groups (n = six per group): sham, fracture + water, fracture + 0.5× (206 mg/kg) ACC, fracture + 1× ACC (412 mg/kg), and fracture + 1.5× (618 mg/kg) ACC, where ACC refers to the equivalent supplemental dose of ACC for humans. A 21-gauge needle was placed in the left femoral shaft, and we then waited for three weeks. After three weeks, the sham group of rats was left without fractures, while the remaining animals had their left mid-femur fractured with an impactor, followed by treatment with different doses of oral ACC for three weeks. Weight-bearing capacity, microcomputed tomography, and serum biomarkers were evaluated weekly. After three weeks, the rats were sacrificed, and their femur bones were isolated to conduct an evaluation of biomechanical strength and histological analysis. Results: Weight-bearing tests showed that treatment with ACC at all the tested doses led to a significant increase in weight-bearing capacity compared to the controls. In addition, microcomputed tomography and histological studies revealed that ACC treatment improved callus formation dose-dependently. Moreover, biomechanical strength was improved in a dose-dependent fashion in ACC-treated rats compared to the controls. In addition, supplementation with ACC significantly lowered bone formation and resorption marker levels two–three weeks post-fracture induction, indicating accelerated fracture recovery. Conclusions: Our preliminary data demonstrate that ACC supplementation improves fracture healing, with ACC-supplemented rats healing in a shorter time than control rats.

9 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LMLokesh Kumar Mende
Lokesh Kumar Mende
MLMeng-Lin Lee
Meng-Lin Lee
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
SKShu-Yi Koh
Shu-Yi Koh
CWChih-Shung Wong
Chih-Shung Wong
Objective: Morphine is a widely used analgesic for severe pain, but tolerance is a major challenge in long-term pain management. This study examined the potential of Daflon® to enhance morphine’s pain-relieving effects and to reduce tolerance in a rat model with neuropathic pain induced by partial sciatic nerve transection (PSNT). Methods: Male Wistar rats were divided into five groups: (1) Sham + Saline, (2) PSNT + Saline, (3) PSNT + morphine, (4) PSNT + Daflon, and (5) PSNT + morphine + Daflon. Morphine tolerance was induced through continuous intrathecal infusion (15 µg/µL/h, i.t.) for 7 days, starting on day 7 post-PSNT, while Daflon was administered orally (50 mg/kg/day, oral) for 7 days. Pain relief was assessed using tail-flick and paw withdrawal on days 1, 4, and 7 after osmotic pump implantation. Spinal cords were collected for immunohistochemistry to analyze glial expression, and serum biomarkers (TNF-α, IL-1β, IL-6, and IL-10) were measured to evaluate neuroinflammation. Results: The results showed that oral Daflon significantly enhanced morphine’s analgesic effects, evidenced by improved pain thresholds in all behavioral tests. Moreover, Daflon reduced morphine tolerance. Mechanistically, Daflon upregulated the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and activated heme oxygenase-1 (HO-1), reducing oxidative stress and modulating neuroinflammation through glial regulation. Combining morphine and Daflon reduces pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) and enhances anti-inflammatory IL-10 serum level, showing a synergistic effect in managing neuropathic pain with greater efficacy and lower drug dependence. Histology and immunohistochemistry evaluations further confirmed that morphine and Daflon co-treatment substantially reduced mononuclear cell infiltration, astrocyte activation (as indicated by GFAP expression), and microglial activation (as indicated by Iba-1 expression) compared to single treatment. Conclusions: Our findings suggest that dual therapy synergistically targets both oxidative stress and inflammatory pathways, leading to stronger neuroprotection and pain relief. Importantly, the combination approach may allow for lower opioid dosages, minimizing the risks of opioid-related side effects. Overall, morphine and Daflon co-administration offers a promising and safer strategy for managing neuropathic pain and preserving spinal cord integrity.

13 July 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
LMLokesh Kumar Mende
Lokesh Kumar Mende
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
CWChih-Shung Wong
Chih-Shung Wong
Background: Osteoarthritis (OA) is mainly driven by mechanical damage together with persistent oxidative stress and synovial inflammation, leading to progressive cartilage loss and functional impairment. We evaluated the protective effect of vitamin D and curcumin alone or in combination on OA progression and outcomes in an anterior cruciate ligament transection plus medial meniscectomy (ACLT + MMx) rat model. Methods: OA was induced by ACLT + MMx surgery. Rats were assigned to Sham, OA-control (Control), vitamin D, curcumin, and Vitamin D + Curcumin groups (n = 6/group). Functional outcomes (knee width/swelling and weight-bearing Δ force) and body weight were monitored for 12 weeks. Cartilage damage was assessed by H&E histology and quantitative histomorphometry (cartilage thickness/width) together with degeneration OARSI score assessment. Mechanistic readouts included qPCR for Nrf2 and HO-1, serum oxidative stress markers (MDA, GSSG, CAT), and synovial cytokines (TNF-α, IL-1β, IL-10, MCP-1). Results: OA-control rats showed clear functional deterioration (greater knee swelling and impaired weight bearing), pronounced histological cartilage degeneration, and higher degeneration/OARSI scores. Vitamin D or curcumin treatment improved functional measures, preserved cartilage structure, and reduced cartilage degeneration indices. These benefits were generally strongest with the combined Vitamin D + Curcumin treatment, which showed the greatest overall preservation of cartilage integrity. Treatments were associated with increased synovial Nrf2/HO-1 mRNA expression, improved oxidative stress balance, and a shift toward a less inflammatory synovial cytokine profile. Conclusions: Vitamin D and curcumin, particularly in combination, showed cartilage-protective and functional benefits in ACLT + MMx-induced OA, possibly through coordinated reduction in oxidative stress and synovial inflammation together with increased antioxidant-related Nrf2/HO-1 expression.

12 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
TYTsu-Te Yeh
Tsu-Te Yeh
CCChun-Kai Chen
Chun-Kai Chen
Yaswanth KuthatiYaswanth Kuthati
Yaswanth Kuthati
LMLokesh Kumar Mende
Lokesh Kumar Mende
ZKZwe-Ling Kong
Zwe-Ling Kong
CWChih-Shung Wong
Chih-Shung Wong
Delayed and failed fracture repair and bone healing remains a significant public health issue. Dietary supplements serve as a safe, inexpensive, and non-surgical means to aid in different stages of fracture repair. Studies have shown that amorphous calcium carbonate (ACC) is absorbed 2 to 4.6 times higher than crystalline calcium carbonate in humans. In the present study, we assessed the efficacy of Density ACC supplement on femoral fracture healing in a male Wistar rat model. Fifty male Wistar rats were divided into five groups (n = 6 per group); Sham, Fracture + Water, Fracture + 0.5x (206 mg/kg) ACC, Fracture + 1x ACC (412 mg/kg) and Fracture + 1.5x (618 mg/kg) ACC to that of human supplement doses of ACC. A 21-gauze needle was placed in the left femoral shaft and waited three weeks. After three weeks, the sham group of rats was left without fracture, and the remaining animals were fractured with an impactor at the left mid-femur, followed by treatment with different doses of ACC for three weeks orally. Weight-bearing, microcomputed tomography, and serum biomarkers were evaluated weekly. After three weeks, the rats were sacrificed and femur bones were isolated for the evaluation of biomechanical strength and histological analysis. Weight-bearing test showed that treatment with ACC at all the tested doses led to a significant increase in weight-bearing compared to the controls. In addition, microcomputed- tomography and histological studies revealed that ACC treatment improved callus formation dose-dependently. Moreover, biomechanical strength was better in ACC-treated rats in a dose-dependent fashion than in the controls. In addition, supplementation with ACC significantly lowered the bone formation and resorption (BFR) marker levels 2-3 weeks post-fracture induction indicating accelerated fracture recovery. Our preliminary data demonstrate that ACC supplement improves fracture healing in a shorter time than the control rats.